Will Materials ETFs Gain Further as Q1 Earnings Unfold?
https://www.zacks.com/stock/news/2257915/will-materials-etfs-gain-further-as-q1-earnings-unfold?cid=CS-ZC-FT-etf_news_and_commentary-2257915
Apr 18, 2024 - Going into the Q1 earnings season, earnings releases from the sector giants will determine the movement of these funds.
0
3 Dividend Aristocrats to Take the Edge off Market Volatility
https://www.zacks.com/stock/news/2259379/3-dividend-aristocrats-to-take-the-edge-off-market-volatility?cid=CS-ZC-FT-analyst_blog|investment_ideas-2259379
Apr 22, 2024 - With markets remaining topsy-turvy, it's prudent for astute investors to pick dividend aristocrats like Atmos Energy (ATO), Ecolab (ECL) and SherwinWilliams (SHW) for steady income.
0
Reasons Why You Should Retain HealthEquity (HQY) Stock for Now
https://www.zacks.com/stock/news/2260548/reasons-why-you-should-retain-healthequity-hqy-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2260548
Apr 23, 2024 - HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.
0
Penumbra's (PEN) New Launch to Enhance Blood Clot Removal
https://www.zacks.com/stock/news/2261445/penumbra-s-pen-new-launch-to-enhance-blood-clot-removal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2261445
Apr 24, 2024 - Penumbra's (PEN) latest offering is likely to enable physicians to restore blood flow more quickly and further minimize blood loss.
0
Here's Why You Should Hold Lantheus (LNTH) in Your Portfolio Now
https://www.zacks.com/stock/news/2265409/here-s-why-you-should-hold-lantheus-lnth-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2265409
Apr 30, 2024 - Lantheus' (LNTH) focus on pipeline development raises optimism about the stock.
0
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
https://www.zacks.com/stock/news/2269766/quest-diagnostics-dgx-grows-in-digital-pathology-with-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2269766
May 07, 2024 - Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
0
Are You Looking for a Top Momentum Pick? Why Ecolab (ECL) is a Great Choice
https://www.zacks.com/stock/news/2269824/are-you-looking-for-a-top-momentum-pick-why-ecolab-ecl-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2269824
May 07, 2024 - Does Ecolab (ECL) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
QuidelOrtho (QDEL) Q1 Earnings Beat Estimates, Margins Fall
https://www.zacks.com/stock/news/2271721/quidelortho-qdel-q1-earnings-beat-estimates-margins-fall?cid=CS-ZC-FT-analyst_blog|earnings_article-2271721
May 09, 2024 - QuidelOrtho's (QDEL) first-quarter results reflect growth in revenues, excluding the COVID-19 revenue impact.
0
FMC Corp (FMC) Teams Up With AgroSpheres for Bioinsecticides
https://www.zacks.com/stock/news/2273673/fmc-corp-fmc-teams-up-with-agrospheres-for-bioinsecticides?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2273673
May 14, 2024 - FMC partners with AgroSpheres to accelerate the development of innovative bioinsecticides, enhancing sustainable crop protection and reinforcing FMC's industry leadership.
0
Here's What Makes Reliance (RS) Stock a Solid Choice Right Now
https://www.zacks.com/stock/news/2274017/here-s-what-makes-reliance-rs-stock-a-solid-choice-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2274017
May 15, 2024 - Reliance (RS) gains on strong underlying demand in its major markets and strategic acquisitions.
0